StimuSIL is a medical device company focusing on photobiomodulation with multiple indications in dermatology and aesthetics.
Business Model:
Revenue: $0
Employees: 1-10
Address: 919 North Market Street
City: Wilmington
State: DE
Zip: 19801
Country: US
StimuSIL is a medical device company in the process of developing new technologies for safer and more effective photobiomodulation (PBM) therapy, with the goal of targeting multiple indications in dermatology and aesthetics. StimuSIL’s proprietary technologies aim to deliver PBM across the melanin layer of the skin in order to enhance this treatment’s biostimulatory effects. StimuSIL was established in January 2020 in Washington, D.C. by Pablo Villalba Villar.
Contact Phone:
+14154839399
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2021 | Seed Round | 1 | - |
The Net street The Net street |
8/2022 | Seed Round | $575k | 6/2022 | Equity | $569.7k | 5/2021 | Seed Round | 1 | - |
The Net street The Net street |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|